- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02012816
The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia
The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia: an Impact Evaluation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators propose a cluster randomized design in which the CIDRZ-supported VMMC clinics in the Southern Province in Zambia will be randomly selected to have a peer referral incentive program or not. In approximately 10 randomly selected intervention clinics, all men who reside in the catchment area of the clinic and come for male circumcision services will be eligible to receive 5 referral vouchers that will entitle them to receive monetary compensation for each voucher that is subsequently presented by a man who comes to the clinic and undergoes male circumcision. In 10 remaining clinics (control group), VMMC services will proceed as per the current standard of care, without peer referral incentives. All clinics including those allocated to the control group will have the standard mobilization and promotion activities that are used by CIDRZ.
In intervention clinics:
- All eligible men seeking VMMC in intervention clinics will be asked if they want to participate in the study. This can happen on the day of the circumcision or within 7 days after the circumcision.
- If yes, a file is open for them as "referring person". They receive 5 vouchers. They also receive MC brochures to distribute to friends.
- As his friends or relatives come in as referrals, they are written in his file He can then claim reimbursement any time between the time a referred friend comes for VMMC and the expiration of the voucher. The referring person needs to bring the voucher in order to receive reimbursement.
- Friends who come as referrals are given the possibility to become referring persons too, if within the intervention period. In that case, a new file is open for them as "referring persons".
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lusaka, Zambia
- Center for Infectious Disease Research in Zambia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Inclusion criteria for receiving vouchers: Uncircumcised men 18-49 years old seeking VMMC services and undergoing male circumcision at one of the clinics selected for the study during the 5 months of the active intervention.
Inclusion criteria for a successful referral: The referred person needs to be a previously uncircumcised man 18-49 and seeking VMMC services at that clinic during the 3 months of eligibility for voucher redemption.
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Uncircumcised men
The program allows each man coming for circumcision to refer up to 5 uncircumcised men in their social network for VMMC services and receive a monetary reward for each successful referral.
|
The proposed intervention will allow men coming for male circumcision in randomly selected intervention clinics to refer up to 5 uncircumcised men in their social network and receive a monetary reward for each referred man who undergoes male circumcision.
Men who come for circumcision will each be given 5 referral vouchers that they can then provide to uncircumcised men in their social network who may be interested in undergoing VMMC.
If these uncircumcised men come to the CIDRZ VMMC clinics and undergo the circumcision procedure, they can present the referral voucher to clinic staff who will then retain the voucher until the man who made the referral comes to collect his incentive payment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary outcome will be the number of men coming for circumcision in each clinic during the intervention period divided by the adult male population in the catchment area of each clinic.
Time Frame: 1 year
|
Primary outcome will be the number of men coming for circumcision in each clinic during the intervention period divided by the adult male population in the catchment area of each clinic.
The calculated proportion in the intervention clinics will be compared to the calculated proportion in the control clinics using standard t-test.
|
1 year
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Harsha Thirumurthy, MD, UNC at Chapel Hill
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CIDRZ 1310
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infection
-
Federal University of São PauloGilead SciencesCompleted
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
Fundación HuéspedViiV HealthcareNot yet recruitingHIV-1-infectionArgentina, Brazil
-
Fundación HuéspedMSD Pharmaceuticals LLC; Fundacion IDEAANot yet recruiting
-
Henan Genuine Biotech Co., Ltd.Recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
BioNTech SERecruitingHIV -1 InfectionGermany, United States
-
TaiMed Biologics Inc.Active, not recruitingHIV -1 InfectionUnited States
-
University of North Carolina, Chapel HillNot yet recruiting
-
Craig Cohen, MD, MPHNational Institute of Allergy and Infectious Diseases (NIAID); Duke University and other collaboratorsRecruiting